Gynov is a company dedicated to pioneering genuine, effective, and targeted solutions to various female health concerns. Beyond the qualitative approach based on robust scientific data, the French company designs products integrated not only into medical care but above all into a holistic vision of human health. Gynov, short for Gynecological Innovation, was founded by Pierre-Yves Mousset MD, in France in 2016. The company’s flagship product…
Femtech startup Veera Health has raised $3M in funding co-led by Sequoia Capital India’s Surge and Global Founders Capital for its digital therapeutics platform that supports women with PCOS in India. Other participants include Y Combinator, CloudNine Hospitals’ cofounder Rohit M.A. and Tinder India hear Taru Kapoor. Veera Health was founded by sisters Shobhita and Shashwata Narain in August 2020. The platform…
Inito, a new home fertility test, announced its launch to the U.S. market. The Inito device, paired with a smartphone app, measures the actual hormone values for estrogen, luteinizing hormone and progesterone, and gives users data to guide decisions through the conception process. In addition to the U.S. launch, Inito is also launching a new ‘Hormone Charts’ feature in the app allowing…
Proov, a science-based hormone testing company and the leader in testing urine for PdG to confirm ovulation, is announcing today that it has received CE marking approval for sales of its patented and patent pending PdG tests in Europe. The new European approval will help Proov address the long-awaited arrival of PdG tests by European consumers. Proov PdG tests evaluate for the…
Proov, a science-based hormone testing company and the leader in testing urine for PdG to confirm ovulation, has announced that it has received patent issue notification for its second utility patent for a lateral flow assay test. The patent covers Proov’s novel device to detect the analytes of progesterone and other hormones in a single lateral flow assay. As a first-of-its-kind device…
U.K. based healthtech company Forth has announced the launch of a new Female Hormone Mapping product. It has been designed to give women greater insight and understanding about their hormone cycles to improve their wellbeing and provide answers to female hormone specific issues such as perimenopause and menopause. The product will use two blood samples over a single cycle to give women…
London-based Hashimoto startup Hashiona has announced the close of a €450K pre-seed round. The company was founded in early 2020 and initially launched in January 2021. Hashiona has since acquired hundreds of beta-users, who use the app to track symptoms and connect with providers via telehealth. Draper University, KAYA, DFRI, Calm/Storm, as well as angel investors participated in the round. Hashimoto is an autoimmune disease…
In our “Starter Story” series we invite femtech founders to share their stories of how it all began. How did they come up with the idea? Where did they meet their cofounders and what was the hardest part of going from 0 to 1? In today’s Starter Story we get to share Emme’s founding story as told by co-founder Amanda French. Emme is…
